Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue. The most common etiologic agent encountered in Southern China is from the genus Fonsecaea. Fonsecaea species are often misidentified due to indistinct morphology features; furthermore, recent taxonomy revision was done on the fungi genus. Herein, a comprehensive evaluation with molecular sequencing data based on internal transcribed spacer (ITS) ribosomal DNA regions as molecular targets were implemented to 37 clinical isolates from chromoblastomycosis patients. Twenty strains that were formerly identified as Fonsecaea pedrosoi through morphological characteristic were verified to be either Fonsecaea nubica or Fonsecaea monophora, while 17 strains were appropriately identified as F. monophora. A phylogenetic method was further performed to establish the species delimitation. Our investigations validate that the clinical isolates from Guangdong consist of F. monophora and the recently found new species, F. nubica. In this study, F. pedrosoi has not been isolated from chromoblastomycosis patients in Guangdong, Southern China. Reevaluation of previous reports regarding F. pedrosoi as chromoblastomycosis etiologic agent in China is necessary for a comprehensive assessment of geographic distribution pattern of Fonsecaea species. This study is the first reported study presenting large samples of F. nubica domestic or abroad.
Introduction
The recent taxonomic revision of the genus Fonsecaea causing human chromoblastomycosis (CBM) based on molecular data has recognized four species including Fonsecaea pedrosoi, 1 Fonsecaea monophora, 2, 3 Fonsecaea nubica, 4 and Fonsecaea pugnacius. further reviewed the species recognition and demarcation. 2, 3 In 2010, F. nubica was acknowledged as a novel species separated from the genotype F. pedrosoi through multilocus molecular data. 4 F. nubica showed prevalence toward Chinese population and several species were also found in other regions such as South America, Europe and Africa. 3, 4, 6 In 2015, the latest finding of new Fonsecaea species was discovered in Brazil and named F. pugnacius. 6 Although the four types of Fonsecaea species have similar morphology, their pathogenicity is different from one another. F. pedrosoi and F. nubica appear to be exclusively associated with CBM, whereas F. monophora, beside CBM, was found to cause infections in other organs, including the brain, gallbladder, and lymph node. [7] [8] [9] In Fonsecaea pugnacius infection, both the skin and brain were affected where sclerotic cells were found in the skin while hyphae in the brain. 5 The aim of the present study was to perform ITS rDNA molecular sequencing and phylogenetic analysis on 37 clinical isolates morphologically classified as F. pedrosoi and F. monophora for accurate identification of chromoblastomycosis etiologic agent and clarification of the species delineation.
Materials and methods

Strains and morphology
A total of 37 strains isolated from skin lesions of Chinese patients diagnosed with CBM and 59 reference strains from the Centraalbureau voor Schimmelcultures (CBS) collection (23 strains that have previously been evaluated by ITS analysis were from our department and 36 reference strains from other countries) were investigated in this study. Isolated clinical strains were grown at 26
• C on Sabouraud's glucose agar (SGA) and potato dextrose agar (PDA) plates for 2-3 weeks. For morphological studies, slide cultures were prepared and stained with lactophenol cotton blue dye.
Physiology
Thermotolerance was investigated on SGA plates for 2 weeks at 26, 37, and 40
• C. Cycloheximide resistance was performed on SGA plates using different concentrations of 0.1, 0.05, and 0.01%. The hydrolysis of urea was tested using Christensen's urea agar. Inoculated plates were incubated at 26
• C, and the results were considered positive if the medium turned pink in 4 days. The growth responses were scored as positive (+), negative (−), weak (w), and ambiguous (w/−/ or w/ +). Table 1 .
Phylogenetic analysis
A phylogenetic method was used to explore the relationships among the 96 Fonsecaea strains comprising 37 clinical isolates and 59 standard strains retrieved from the GenBank database. Two Cladophialophora carrionii strains were chosen as members of outgroup. ITS sequences were aligned using MUSCLE, and a consensus tree was constructed with MEGA 6.0 using 500 bootstrap replicates.
Clinical data analysis
All the clinical data (including age, sex, site of predilection, and etiologic agent) of CBM patients available in our department that have been analyzed by molecular identification were evaluated.
Results
The 37 clinical isolates showed colony characteristic of Fonsecaea species, which is slow growing, velvety, dark brown to black color colony, and typical morphology with conidiogenesis process (Fig. 1) . The growth of all strains was observed in the temperature range between 26 and 37 • C. The maximum growth temperature was 37
• C, and no growth was observed at 40
• C. Urea test result was ambiguous or weakly hydrolyzed. All the isolates were tolerant to cycloheximide at all the concentrations used in this study. Among the 37 Fonsecaea clinical strains identified through ITS rDNA sequence analysis, 25 strains were classified as F. monophora, and 12 strains were F. nubica (Table 2) . Twenty strains that were formerly identified as F. pedrosoi through morphological characteristic were verified to be either F. nubica or F. monophora, while 17 strains were appropriately identified as F. monophora.
There were four major clusters observed in the phylogenetic tree (Fig. 2) based on ITS rDNA sequencing data; they are F. pedrosoi (cluster A), F. monophora (cluster B), 
F. nubica (cluster C), and F. pugnacius (cluster D)
. Cluster B, representing F. monophora, was further subdivided into three subgroups: subgroup B1, B2, and B3.
F. pedrosoi strains in cluster A were mainly recovered from North America and South America, two strains were from Japan, and one from North Africa. The F. monophora strains in subgroup B1 were mainly recovered from South America, prevalently Brazil, except for strain SUMS0411 from Southern China. Subgroup B2 consisted of strains from Eastern China. Subgroup B3 consisted of strains primarily recovered from Southern China except for two brain isolates, CBS 117236 and CBS 117238 from the United States and United Kingdom, respectively. F. nubica strains in cluster C consisted of 15 strains from China and a few other strains recovered from Brazil, Suriname, and West Cameroon.
From all 60 CBM patients' data in our department, it was found that 87% of CBM patients were male (n = 52/60) and 13% were female (n = 8/60). The mean age was 59 years old (ranging from 29 to 83). CBM lesions were mostly found on the lower limbs, 66% (n = 33/50), followed by upper limbs, 28% (n = 14/50), buttocks, 4% (n = 2/50) and face, 2% (n = 1/50). For the etiologic agents of CBM, 75% (n = 45/60) were F. monophora, and 25% (n = 15/60) were F. nubica (Table 3 ). The types of chromoblastomycosis clinical manifestation include plaque, tumoral, nodular, verrucous, cicatricial, eczymatous, pseudovacuole, and mixed type lesion.
Discussion
Chromoblastomycosis disease is found worldwide, with higher incidence in tropical and subtropical regions. Countries with the highest number of cases where chromoblastomycosis is endemic are Madagascar and Brazil, where F. pedrosoi is the main pathogenic agent. [10] [11] [12] In China, there were more than 500 cases reported since 1952 with C. carrionii as the predominant pathogenic agent in Northern China and F. monophora in Southern China. 3 The sibling species of the genus Fonsecaea causing human chromoblastomycosis only have slight distinction on morphological features where experts and in-depth examination are indispensable, which make it a frequently inadequate tool for correct species identification.
Species identification is essential as the pathogenic potential of Fonsecaea species is fairly different from one another, F. pedrosoi and F. nubica appear to be exclusively correlated with CBM, 1,4 whereas F. monophora and F. pugnacius, beside CBM, could cause infections in other organ.
5, 7-9 However, unlike F. monophora, which could cause primary brain phaeohyphomycosis, the pathogenic potential of Fonsecaea pugnacius is different because infection in the brain was secondary to chromoblastomycosis lesions found in the upper arm and face. 5 Formerly, the three Fonsecaea strains (SUMS0255, SUMS0251, SUMS0011) from Southern China and a few strains from other countries that were previously 1, 3 were later proven to be members of a new species, F. nubica, through multilocus molecular data using ITS, cdc42, tub1 and act1. 4 The revelation of F. nubica species had provided an approach to further identify Fonsecaea species accurately. In this study, molecular analysis using ITS ribosomal DNA region is appropriate for the species identification and the phylogenetic analysis further supports the findings. In this study, through ITS sequence analysis, only F. monophora had several notable subgroups, strains in South America were distinguished from strains in China, and isolates in Southern China were separated from isolates in Eastern China. Report by Sun et al. 13 comparing six sequencing genes showed that beside the two subgroups observed in F. monophora, within F. nubica, two subgroups were observed in cdc42, Lac, and HmgA genes. The first subgroup comprised F. nubica strains from Europe and South America, and the second subgroup comprised strains from Africa and China. These three genes were more specific for F. nubica delineation, as these definitions were not seen in ITS, BT2, or act1 genes. Similar groupings were observed through the use of AFLP fingerprinting with an automatic cutoff value option set at < 62.5% similarity. 6 Fonsecaea monophora strains in cluster B1 were predominant in South America except for strain SUMS0411 from China. The strains in cluster B3 were predominant in Southern China except for two cases of brain infections, CBS 117236 from the United States and CBS 117238 from the United Kingdom' nonetheless, there is no documentation of these two patients having had travelled to China. In similar data from Japan, these two strains were incorporated into an independent subgroup. 9 More strains from the two species origins are required to verify the appropriate topology of the species. For these three distinct patients, the possibility of acquiring the infection when abroad could not be concluded. Despite a few poor placements in the phylogenetic tree, an apparent geographical structuring is significant, implying that the dispersal vectors of Fonsecaea species are slow. During the last 10 years, more than 60 confirmed cases of chromoblastomycosis were found in our dermatology department; among them after reidentification with molecular data, F. monophora was still found to be the most common etiological agent in Southern China. In this study, CBM infection by F. monophora and F. nubica both showed male predominance and most commonly affect the lower limbs. Bonifaz et al. 14 reported 51 CBM cases where 70% of the patients were male, 74% were farmers, and 54% of the lesions were found on the lower limbs. Similar findings were obtained in a study of 27 Brazilian patients where 85% of the patients were male and 59.2% of the lesions were on the lower limbs. 15 Najafzadeh et al. reported an even higher male to female ratio of patients with a ratio of 63:2. 5 However, data from Japan showed similar sex ratio, while lesions were most often localized on the upper limbs. 16 For the male predominance, beside their engagement in agricultural work making them prone to traumatic injuries, female sexual hormone, and genetic factor seem to play a role in the disease susceptibility. There were findings suggesting the role of female hormone in inhibiting fungal development; estrogens inhibited the transition of Paracoccidioides brasiliensis mycelial or conidial form into the infective yeast form, and progesterone inhibited the growth of P. verrucosa. 17, 18 It is likely that steroid hormone could also contribute to the sex prevalence in CBM. As for the genetic factor, there is increased susceptibility to chromoblastomycosis in the presence of HLA-A29 antigen. 19 Lu et al. 20 have previously described the seven clinical types of chromoblastomycosis lesion in Southern China and comprehensive clinical classification were described by Queiroz-Telles et al. 21 including the plaque, verrucous, tumoral, nodular, cicatricial, eczymatous, pseudo-vacuole, and mixed type lesion, the first five being most commonly encountered lesions, respectively, in this study. There were no significant difference observed between the type of chromoblastomycosis clinical manifestation and the etiologic pathogen. With the progression of the disease and late detection, more than one clinical presentation is often observed. This study reveals that F. pedrosoi as the etiologic agent of chromoblastomycosis has not been recovered from clinical isolates in Guangdong, Southern China. Reevaluation of previous reports with regards to F. pedrosoi as chromoblastomycosis etiologic agent in China is mandatory for accurate geographic distribution pattern of Fonsecaea species. This report validates that the clinical isolates from Guangdong consist of F. monophora and F. nubica. Furthermore, this study is the first reported study presenting large samples of Fonsecaea nubica (15 in total) domestic or abroad.
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